AXGN - AxoGen, Inc.
NEXT EARNINGS:
May 6, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$38.38
DETAILS
HIGH:
$41.00
LOW:
$34.00
MEDIAN:
$39.50
CONSENSUS:
$38.38
UPSIDE:
18.09%
Market Cap:
1.63B
Volume:
2,279,986
Avg Volume:
928,961
52 Week Range:
9.22-36
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.96
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
451
IPO Date:
1986-12-17
EPS (TTM):
-0.34
P/E Ratio:
-95.98
Revenue (TTM):
225.21M
Total Assets:
221.69M
Total Debt:
19.24M
Cash & Equiv:
35.55M
Rev Growth (5Y):
14.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-10.0%
ROCE:
N/A
Debt/Equity:
0.15
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-0.28 | $0.08 | -450.4% | $59.9M | $59.9M | 0.0% |
| 2025-10-29 | $0.12 | $0.09 | +33.3% | $60.1M | $59.9M | +0.3% |
| 2025-08-05 | $0.12 | $0.06 | +100.0% | $56.7M | $56.9M | -0.4% |
| 2025-05-08 | $-0.02 | $-0.01 | -100.0% | $48.6M | $53.3M | -9.0% |
| 2025-02-25 | $0.08 | $0.04 | +100.0% | $49.4M | $48.3M | +2.3% |
| 2024-11-07 | $0.07 | $0.01 | +1066.7% | $48.6M | $47.4M | +2.5% |
| 2024-08-08 | $0.05 | $-0.05 | +200.0% | $47.9M | $43.4M | +10.4% |
| 2024-05-02 | $-0.06 | $-0.10 | +40.0% | $41.4M | $43.4M | -4.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 225.21M | 187.34M | 159.01M | 138.58M | 127.36M | 112.30M | 106.71M | 83.94M | 60.43M | 41.11M | 27.33M | 16.82M |
| Net Income | (15.70M) | (9.96M) | (21.72M) | (28.95M) | (26.98M) | (23.79M) | (29.12M) | (22.40M) | (10.45M) | (14.41M) | (13.36M) | (17.71M) |
| EPS | -0.34 | -0.23 | -0.51 | -0.69 | -0.65 | -0.60 | -0.74 | -0.60 | -0.31 | -0.47 | -0.51 | -1.00 |
| Total Assets | 221.69M | 203.73M | 196.83M | 195.39M | 208.02M | 201.38M | 154.64M | 160.17M | 58.87M | 46.36M | 37.55M | 16.40M |
| Total Debt | 19.24M | 68.69M | 69.29M | 67.43M | 67.45M | 54.63M | 4.93M | 63,000 | 24.64M | 24.31M | 25.55M | 25.09M |
| Cash & Equivalents | 35.55M | 27.55M | 31.02M | 15.28M | 32.76M | 48.77M | 35.72M | 24.29M | 36.51M | 30.01M | 25.91M | 8.22M |
| Operating Cash Flow | 812,000 | 4.54M | (5.72M) | (16.07M) | (13.40M) | (9.63M) | (19.87M) | (17.86M) | (9.24M) | (11.20M) | (13.05M) | (10.45M) |
| Free Cash Flow | (2.93M) | 11,000 | (20.63M) | (37.32M) | (41.80M) | (32.22M) | (25.10M) | (24.46M) | (10.53M) | (12.39M) | (13.61M) | (11.05M) |
| FCF per Share | -0.06 | 0.00 | -0.48 | -0.89 | -1.01 | -0.81 | -0.64 | -0.66 | -0.32 | -0.40 | -0.52 | -0.62 |
| Book Value | 128.85M | 103.91M | 95.67M | 101.00M | 112.55M | 123.15M | 132.15M | 146.98M | 25.18M | 14.92M | 8.20M | (11.25M) |
| Cash & ST Investments | 35.55M | 33.48M | 31.02M | 48.79M | 84.09M | 103.97M | 96.51M | 116.61M | 36.51M | 30.01M | 25.91M | 8.22M |
| ROC Equity | -0.12 | -0.10 | -0.23 | -0.29 | -0.24 | -0.19 | -0.22 | -0.15 | -0.41 | -0.97 | -1.63 | N/A |